Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 14,853 Maze Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Bernstein Harold (President, R&D & CMO) sold 14,853 Maze Therapeutics, Inc. shares at an average US$25.66 for US$381K under a trading plan, leaving 0 shares. Filed Jun 3, 2026 (Form 4).

Sold: 14,853 shares
Price: US$25.66 average (US$25.57 to US$26.36)
Value: US$381K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D & CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 1, 2026	Common Stock	Option exercise	14,853	US$10.42	14,853	Direct
Jun 1, 2026	Common Stock	Sale	13,253	US$25.57	1,600	Direct
Jun 1, 2026	Common Stock	Sale	1,600	US$26.36	0	Direct

Source

View original at SEC

Related